Addressing the Challenges in the Identification of HER2-Low and Ultralow Breast Cancer in Asia: A Delphi Consensus

Key Points

• This study aims to establish consensus on the identification practices for HER2-low and ultralow breast cancer in Asia.
• Conducted a Delphi consensus approach.
• Engaged experts in breast cancer pathology and treatment.
• Focused on sampling, testing, interpretation, and reporting standards.
• Achieved strong consensus among experts on key concepts.
• Identified alignment with existing guidelines.
• Highlighted the need for more evidence on clinical implications.